APA (7th ed.) Citation

X, Z., G, Y., H, Y., B, K., Y, Z., Y, H., . . . P, B. (2025). FBLN7 KO attenuates age-related cardiac fibrosis by promoting TGFBR3/ALK1/Smad1 signaling and inhibiting the profibrotic phenotypes of cardiac fibroblasts. Theranostics, 15(16), 8531. https://doi.org/10.7150/thno.116477

Chicago Style (17th ed.) Citation

X, Zheng, et al. "FBLN7 KO Attenuates Age-related Cardiac Fibrosis by Promoting TGFBR3/ALK1/Smad1 Signaling and Inhibiting the Profibrotic Phenotypes of Cardiac Fibroblasts." Theranostics 15, no. 16 (2025): 8531. https://doi.org/10.7150/thno.116477.

MLA (9th ed.) Citation

X, Zheng, et al. "FBLN7 KO Attenuates Age-related Cardiac Fibrosis by Promoting TGFBR3/ALK1/Smad1 Signaling and Inhibiting the Profibrotic Phenotypes of Cardiac Fibroblasts." Theranostics, vol. 15, no. 16, 2025, p. 8531, https://doi.org/10.7150/thno.116477.